Jason Drew Smith Uro Gen Pharma Ltd. (URGN) insider trading activity

Jason Drew Smith is General Counsel of UroGen Pharma Ltd.. Currently has a direct ownership of 43,305 shares of URGN, which is worth approximately $855,273. The most recent transaction as insider was on Sep 08, 2025, when has been sold 1,520 shares (Ordinary Shares) at a price of $19.11 per share, resulting in proceeds of $29,047. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 43.3K

33.19% 3M change

71.67% 12M change

Total Value Held $855,273

Jason Drew Smith Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 08 2025	SELL Open market or private sale	$29,047 $19.11 p/Share	1,520 Reduced 3.39%	43,305 Ordinary Shares
Sep 07 2025	BUY Exercise of conversion of derivative security	-	3,333 Added 6.92%	44,825 Ordinary Shares
Jul 28 2025	SELL Open market or private sale	$143,971 $19.14 p/Share	7,522 Reduced 15.35%	41,492 Ordinary Shares
Jul 28 2025	BUY Exercise of conversion of derivative security	-	16,500 Added 25.19%	49,014 Ordinary Shares
Jan 31 2025	SELL Open market or private sale	$82,202 $11.14 p/Share	7,379 Reduced 18.5%	32,514 Ordinary Shares
Jan 31 2025	BUY Exercise of conversion of derivative security	-	14,667 Added 29.36%	35,281 Ordinary Shares
Sep 09 2024	SELL Open market or private sale	$19,894 $13.08 p/Share	1,521 Reduced 5.69%	25,226 Ordinary Shares
Sep 09 2024	BUY Exercise of conversion of derivative security	-	3,333 Added 11.08%	26,747 Ordinary Shares
Jan 31 2024	SELL Open market or private sale	$78,589 $15.74 p/Share	4,993 Reduced 17.58%	23,414 Ordinary Shares
Jan 31 2024	BUY Exercise of conversion of derivative security	-	10,000 Added 27.22%	26,742 Ordinary Shares
Aug 31 2023	SELL Open market or private sale	$68,438 $18.01 p/Share	3,800 Reduced 17.11%	18,407 Ordinary Shares
Aug 31 2023	BUY Exercise of conversion of derivative security	-	8,334 Added 27.29%	22,207 Ordinary Shares
Jan 31 2023	SELL Open market or private sale	$16,556 $10.12 p/Share	1,636 Reduced 10.55%	13,873 Ordinary Shares
Jan 31 2023	BUY Exercise of conversion of derivative security	-	3,333 Added 18.08%	15,100 Ordinary Shares
Aug 31 2022	SELL Open market or private sale	$25,999 $7.21 p/Share	3,606 Reduced 22.85%	12,176 Ordinary Shares
Aug 31 2022	BUY Exercise of conversion of derivative security	-	8,333 Added 34.56%	15,782 Ordinary Shares
Jan 31 2022	SELL Open market or private sale	$3,138 $7.58 p/Share	414 Reduced 5.27%	7,449 Ordinary Shares
Jan 31 2022	BUY Exercise of conversion of derivative security	-	833 Added 9.58%	7,863 Ordinary Shares
Nov 30 2021	SELL Open market or private sale	$45,750 $12.03 p/Share	3,803 Reduced 35.11%	7,030 Ordinary Shares
Nov 30 2021	BUY Exercise of conversion of derivative security	-	8,333 Added 43.48%	10,833 Ordinary Shares
May 17 2021	BUY Open market or private purchase	$39,275 $15.71 p/Share	2,500 Added 50.0%	2,500 Common Stock

JDS

Jason Drew Smith

General Counsel

Princeton, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells URGN shares.

Notify only if

Value

Insider Trading

Get notified when an Uro Gen Pharma Ltd. insider buys or sells URGN shares.

Notify only if

Operation

Value

Type

News

Receive news related to UroGen Pharma Ltd.

Track Activities on URGN

Account